What to Expect During a Visit to GentleCure Clinics
Visiting GentleCure clinics means exploring Image-Guided Superficial Radiation Therapy (IGSRT) as a non‑surgical option for common skin cancers such as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). For many people concerned about facial scarring or surgical recovery, GentleCure positions IGSRT as a surgery‑free alternative that uses ultrasound imaging to guide low‑energy X‑ray treatments targeted to the skin lesion. This article explains what a typical visit looks like, why some clinicians offer the GentleCure model in dermatology offices, and the practical questions patients should ask before starting treatment. Please note: this article is informational and not a substitute for medical advice; speak with a licensed dermatologist or radiation oncologist about your specific case.
How GentleCure and Image‑Guided SRT work: background and who provides it
GentleCure is a trademarked approach to Image‑Guided Superficial Radiation Therapy offered through a network of dermatology practices and clinics. The technology combines superficial radiotherapy (low‑penetration X‑rays) with high‑frequency ultrasound imaging to measure tumor depth and guide dosing. The platform commonly used in this model is a dedicated SRT device with ultrasound capability, which allows clinicians to visualize and track a lesion throughout the course of treatment. Clinics offering GentleCure often work in partnership with SkinCure Oncology or deploy similar image‑guided protocols to deliver office‑based radiotherapy on an outpatient schedule.
Key components of a first visit and initial consultation
Your first appointment at a GentleCure clinic typically begins with a thorough review of your medical history, confirmation of the pathology (biopsy results), and a focused skin exam. Expect a provider—often a dermatologist working with trained radiation therapists—to review alternatives such as surgical excision, Mohs micrographic surgery, topical therapy, or observation, and to explain why IGSRT might be appropriate for your lesion. The clinic will usually perform a baseline high‑frequency ultrasound scan to define tumor depth and lateral spread; this scan informs energy selection (e.g., 50, 70 or 100 kV) and the fractionation plan. Administrative steps—insurance verification, a consent discussion, and scheduling—are also completed at this visit, since IGSRT courses are delivered over multiple sessions.
What happens during a treatment session: procedures and timing
Treatment sessions are brief and performed in the dermatology office. After the treatment site is trimmed or prepped, the operator positions shielding and aligns the SRT applicator. Ultrasound guidance helps confirm the lesion’s depth just before delivering a short burst of low‑energy X‑rays. A typical session lasts roughly 15–30 minutes; the actual radiation application usually takes only tens of seconds. Courses are most commonly delivered two to three times per week across several weeks, with many published protocols reporting a mean of about 20 fractions for early‑stage non‑melanoma skin cancers. During the course, clinicians will perform periodic skin checks and may repeat ultrasound imaging to document response.
Benefits to expect and important considerations
Patients often choose GentleCure for cosmetic reasons and to avoid surgical wounds: IGSRT is non‑invasive, generally painless during application, and typically does not require sutures or postoperative wound care. Reported outcomes in modern series show high local control for appropriately selected early‑stage lesions, and many patients report good cosmetic results. However, considerations include treatment duration (multiple visits over weeks), potential acute skin reactions (redness, peeling, temporary pigment change), and the theoretical long‑term risk of radiation‑related effects. Insurance coverage varies by plan and by location; clinics usually assist with prior authorization but patients should confirm benefits beforehand. Finally, IGSRT may not be the best option for advanced tumors, aggressive histologic subtypes, or lesions with deep invasion; a multidisciplinary discussion is often appropriate.
Trends, evidence, and the current clinical context
Interest in image‑guided superficial radiotherapy has grown as several retrospective and prospective series report strong local control and favorable cosmetic outcomes for early‑stage BCC and SCC when patient selection follows established criteria. Clinics are increasingly integrating ultrasound guidance to better tailor energy and dosing and to document tumor response. At the same time, experts emphasize that long‑term, prospective comparative trials are limited compared with the large body of data supporting surgical approaches like Mohs surgery, so ongoing research and careful follow‑up are important. In practice, many dermatology centers now offer IGSRT as one of several treatment options, and national organizations recommend considering radiotherapy for patients who are poor surgical candidates or who prioritize cosmetic preservation.
Practical tips: preparing for your GentleCure appointment and questions to ask
Before attending your first treatment, bring your biopsy pathology report and any prior imaging or operative notes. Wear loose, comfortable clothing and allow time for registration and a pre‑treatment consultation. Useful questions to ask the clinic include: Who will perform and supervise my treatments? What device will be used and will ultrasound imaging be done each visit? How many fractions are planned, and what is the expected total treatment time? What acute side effects should I expect, and what aftercare do you recommend? Also confirm the follow‑up schedule and what the clinic’s documented local control and cosmetic outcome data are for lesions like yours. If insurance coverage is uncertain, request a written estimate and ask whether financial counseling or payment plans are available.
Balancing benefits with risks: patient selection and follow‑up
IGSRT tends to be most appropriate for small, superficial, early‑stage non‑melanoma skin cancers where preserving appearance is a priority and where histology, size, and depth fall within established selection criteria. Older patients, those with medical conditions that impair wound healing, or people with lesions in cosmetically sensitive areas often consider this non‑surgical approach. Regardless of initial response, radiation‑treated sites require long‑term surveillance because skin cancer recurrence can occur months to years after therapy. Clinics typically schedule regular follow‑ups and may use ultrasound or clinical exams to monitor for recurrence; if there is any concern, a biopsy should be performed promptly.
Final thoughts
Visiting a GentleCure clinic will usually feel different from a surgical consultation: expect imaging‑guided planning, short office procedures repeated over weeks, and a strong emphasis on cosmetic outcomes and documentation of response. The approach offers a viable, non‑surgical option for many patients with early‑stage BCC and SCC, but it is not universally superior to surgery—selection, informed consent, and long‑term follow‑up matter. If you are considering GentleCure or another form of IGSRT, request a clear explanation of expected benefits and risks, ask about published results for similar tumors, and consider a second opinion if you have any doubts.
| Visit / Step | What to expect | Typical time |
|---|---|---|
| Initial consultation | Medical review, biopsy confirmation, baseline ultrasound, consent and scheduling | 30–60 minutes |
| Simulation / planning | Ultrasound mapping of lesion depth and margin marking | 15–30 minutes |
| Treatment session | Setup, ultrasound check, short burst of X‑rays, brief recovery instructions | 15–30 minutes per visit |
| Follow‑up visits | Clinical exam ± ultrasound to document healing and check for recurrence | 10–30 minutes |
Frequently asked questions
Q: How many visits will I need?Most modern IGSRT courses for early‑stage lesions use roughly 18–25 treatment fractions, delivered two to three times per week over several weeks. Exact counts vary by lesion depth and protocol; your clinic will tailor the plan.
Q: Is the treatment painful?Treatment is generally well tolerated; patients typically describe little to no pain during radiation delivery. Some people experience transient redness, peeling, or mild discomfort afterward.
Q: Will insurance cover GentleCure / IGSRT?Coverage varies by insurer and plan. Many clinics help with prior authorization and can provide estimates; always confirm benefits and any out‑of‑pocket costs before treatment.
Q: Can I have surgery later if radiation doesn’t work?Yes. If a lesion persists or recurs after IGSRT, surgical options—including Mohs surgery—remain available, though prior radiation can affect tissue characteristics and surgical planning, so discuss contingencies in advance.
Sources
- GentleCure — About Us (SkinCure Oncology) — overview of the GentleCure trademark, treatment model and technology.
- GentleCure — Clinical Study Overview — summary of published research and protocols related to Image‑Guided Superficial Radiotherapy.
- Tran A et al., J Cancer Res Clin Oncol (2023) — Analysis of IGSRT in outpatient dermatology — peer‑reviewed study describing typical fractionation, outcomes and follow‑up.
- Treasure Coast Dermatology — Image‑Guided SRT patient information — example clinic page describing patient experience, scheduling and FAQ.
Health disclaimer: This article summarizes published information and typical clinical practice but does not replace individualized medical advice. If you have been diagnosed with skin cancer or are exploring treatment options, consult your dermatologist, a radiation oncologist, or another qualified clinician to discuss the best plan for your situation.
This text was generated using a large language model, and select text has been reviewed and moderated for purposes such as readability.
